Moe Htet Kyaw (Moe H Kyaw)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Systematic Review

Coronavirus Disease

Saccharomyces Cerevisiae

Top Venues

Human vaccines & immunotherapeutics

Expert review of vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Moe Htet Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human vaccines & immunotherapeutics 19 (1) (2023)
Moe Htet Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human vaccines & immunotherapeutics 19 (1) (2023)
Moe Htet Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human vaccines & immunotherapeutics (2023)
Moe Htet Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human vaccines & immunotherapeutics 19 (1) (2023)
Moe Htet Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human vaccines & immunotherapeutics 19 (1) (2023)
Moe Htet Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human vaccines & immunotherapeutics 19 (1) (2023)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
William K K Wu, Moe Htet Kyaw, Bing Yee Suen, Yee Kit Tse, Martin C S Wong, Aric J Hui, Hui Yee Tak, James Y W Lau, Joseph J Y Sung, Francis Ka Leung Chan
Prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas. Gut 69 (2) (2019)